These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The effect of aldose reductase inhibitor, statil, on hyperpermeability of iridial vessels in experimental galactosemic rats. Terubayashi H; Akagi Y Jpn J Ophthalmol; 1989; 33(3):343-7. PubMed ID: 2507812 [TBL] [Abstract][Full Text] [Related]
6. Sorbitol metabolism in the retina, optic nerve, and sural nerve of diabetic rats treated with an aldose reductase inhibitor. Naeser P; Brolin SE; Eriksson UJ Metabolism; 1988 Dec; 37(12):1143-5. PubMed ID: 3143049 [TBL] [Abstract][Full Text] [Related]
7. Fast anterograde axonal transport in wasted and non-wasted diabetic rats; effects of aldose reductase inhibition. Whiteley SJ; Townsend J; Tomlinson DR; Willars GB Diabetes Res; 1986 Nov; 3(9):447-52. PubMed ID: 2435444 [TBL] [Abstract][Full Text] [Related]
8. Muscarinic receptor density is reduced in diabetic rat atria, an effect prevented by the aldose reductase inhibitor, Statil. Kofo-Abayomi A; Lucas PD J Pharm Pharmacol; 1987 Dec; 39(12):1019-21. PubMed ID: 2894428 [TBL] [Abstract][Full Text] [Related]
9. No influence of an aldose reductase inhibitor on glycogen deposition in tubules from streptozotocin diabetic rats. Rasch R; Osterby R J Diabet Complications; 1989; 3(4):198-201. PubMed ID: 2533211 [TBL] [Abstract][Full Text] [Related]
10. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats. Cameron NE; Cotter MA; Robertson S Q J Exp Physiol; 1989 Nov; 74(6):917-26. PubMed ID: 2512591 [TBL] [Abstract][Full Text] [Related]
11. Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'. Willars GB; Calcutt NA; Tomlinson DR Diabetologia; 1987 Apr; 30(4):239-43. PubMed ID: 2439402 [TBL] [Abstract][Full Text] [Related]
12. Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat. Dahlin LB; Archer DR; McLean WG Diabetologia; 1987 Jun; 30(6):414-8. PubMed ID: 2445613 [TBL] [Abstract][Full Text] [Related]
13. Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat. Sima AA; Prashar A; Zhang WX; Chakrabarti S; Greene DA J Clin Invest; 1990 May; 85(5):1410-20. PubMed ID: 2110189 [TBL] [Abstract][Full Text] [Related]
14. [Diabetic changes in pupillary reaction and iridal pathology. No. 1. The role of aldose reductase to the delayed pupillary reaction in galactose-fed rats]. Terubayashi H; Akagi Y; Kador PF; Kinoshita JH Nippon Ganka Gakkai Zasshi; 1988 Mar; 92(3):484-8. PubMed ID: 3137794 [No Abstract] [Full Text] [Related]
15. Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'. Robinson JP; Willars GB; Tomlinson DR; Keen P Brain Res; 1987 Nov; 426(2):339-48. PubMed ID: 2446712 [TBL] [Abstract][Full Text] [Related]
16. The effects of aldose reductase inhibitor on the corneal endothelial morphology in diabetic rats. Matsuda M; Awata T; Ohashi Y; Inaba M; Fukuda M; Manabe R Curr Eye Res; 1987 Feb; 6(2):391-7. PubMed ID: 2952464 [TBL] [Abstract][Full Text] [Related]